One well-documented example is that patients with high CXCL11 expression tend to possess a high abundance of intra-tumor CD8+ T cells and CD56+ NK cell infiltration in the tumor, and those cells are correlated with the anti-tumor immune response, resulting in a favorable prognosis (Tokunaga et al., 2018). This evidence concerns the gene CXCL11 and neoplasm.